Rhythm Pharmaceuticals buy BiotechBee
Start price
12.11.23
/
70%
€25.60
Target price
30.09.25
€35.00
Performance (%)
91.41%
Price
03.10.24
€44.73
Summary
This prediction is currently active. With a performance of 91.41% the BUY prediction by BiotechBee is a big success. This prediction currently runs until 30.09.25. The prediction end date can be changed by BiotechBee at any time. BiotechBee has 70% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Rhythm Pharmaceuticals | - | - |
iShares Core DAX® | -1.114% | 3.430% |
iShares Nasdaq 100 | 1.816% | 6.911% |
iShares Nikkei 225® | 2.113% | 5.501% |
iShares S&P 500 | 2.038% | 5.327% |
According to BiotechBee what are the pros and cons of Rhythm Pharmaceuticals for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Rhythm Pharmaceuticals diskutieren
Buy mit Kursziel 35,0
Stopped prediction by BiotechBee for Rhythm Pharmaceuticals
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€25.20
03.09.23
03.09.23
€35.00
31.12.25
31.12.25
-6.35%
05.09.23
05.09.23
Could be very worthwhile Investment >20% year